Even though the market and the biotech index have both been moving up the last four days, it appears CRA has hit some strong resistance at 6.40 to 6.43:

http://finance.yahoo.com/q/bc?t=5d&s=CRA...

Since volume for those four days adds up only to near 2.1M, we obviously have not had the high-volume buying to punch thru this determined seller. When we do, I expect us to climb rapidly to $6.70-6.80 range were we topped off a couple times this fall.

http://finance.yahoo.com/q/bc?s=CRA&t=6m...

But what is obvious from these charts is that $6 is the floor for this stock. Unless there’s any news to the contrary (and I don’t expect any), I see very little risk on the downside below $6 and I see a whole heck of a lot of reward potential heading on up to $8-9.

And then there is always the chance of some more good partnership or cancer-test news. I really like the odds here.

-the bum